SCHEMBL31354504

SCHEMBL31354504

COC(CCCCCCC(C)OCc1ccccc1)OC

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RCE1 Q9Y256 1/20 0.46
HTT P42858 4/20 0.43
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 2/20 0.37
HDAC2 Q92769 1/20 0.36
TSHR P16473 1/20 0.35
CSNK1E P49674 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SLC1A3 P43003 2/20 0.34
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8918136 0.95 RCE1 (0.47) RCE1HTTKMT2ANPC1MAPT
SCHEMBL31354655 0.86 CSNK1E (0.37) RCE1HTTKMT2AMAPTTSHR
SCHEMBL31354530 0.84 RCE1 (0.41) RCE1HTTKMT2ANPC1MAPT
SCHEMBL27277461 0.83 ALDH1A1 (0.49) KMT2ACSNK1EALDH1A1MEN1
SCHEMBL31470624 0.83 ALDH1A1 (0.49) KMT2ACSNK1EALDH1A1MEN1
SCHEMBL6685008 0.83 ALDH1A1 (0.49) KMT2ACSNK1EALDH1A1MEN1
SCHEMBL31354572 0.83 CSNK1E (0.38) RCE1TSHRCSNK1EALDH1A1TDP1
SCHEMBL27759806 0.82 RCE1 (0.38) RCE1KMT2AMAPTHDAC2TSHR
SCHEMBL31354637 0.82 CTRC (0.42) TSHRCSNK1EALDH1A1TDP1L3MBTL1
SCHEMBL6683665 0.81 ALDH1A1 (0.47) TSHRCSNK1EALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4530281-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-02 EP disclosed
US-20250084028-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-03-13 US disclosed
CN-119569571-A 8- (Acyloxy) alkanal compound, process for producing the same, and process for producing 2, 9-diacetoxy undecane from the 8- (acyloxy) alkanal compound 信越化学工业株式会社 2025-03-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084028-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND CUL1, UBA1, UBE2E1 RCE1 160/4885HTT 4123/4885KMT2A 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.